ProfileGDS5822 / ILMN_1235252
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 36% 40% 37% 6% 20% 65% 41% 26% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 117.136
GSM1276600PDAC Late Ablation Control 220.140
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.237
GSM1276603PDAC Late Ablation 26.86
GSM1276604PDAC Late Ablation 312.220
GSM1303940PDAC Late Ablation_anti-CTLA4 134.365
GSM1303941PDAC Late Ablation_anti-CTLA4 219.941
GSM1303942PDAC Late Ablation_anti-CTLA4 313.226